Title | Type | SJR | H index | Total Docs. (2013) | Total Docs. (3years) | Total Refs. (2013) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2013) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Natural Product Reports | journal | 3.094 Q1 | 211 | 64 | 237 | 11257 | 2411 | 231 | 10.36 | 175.89 | |
2 | Trends in Pharmacological Sciences | journal | 5.425 Q1 | 244 | 92 | 256 | 5973 | 2800 | 240 | 10.36 | 64.92 | |
3 | Nature Reviews Drug Discovery | journal | 7.283 Q1 | 391 | 211 | 686 | 7324 | 7492 | 405 | 9.97 | 34.71 | |
4 | Particle and Fibre Toxicology | journal | 2.857 Q1 | 119 | 64 | 124 | 3015 | 1238 | 119 | 7.57 | 47.11 | |
5 | Neuropsychopharmacology | journal | 5.270 Q1 | 249 | 275 | 785 | 15903 | 6635 | 722 | 7.24 | 57.83 | |
6 | Critical Reviews in Toxicology | journal | 1.948 Q1 | 129 | 47 | 121 | 5822 | 868 | 113 | 6.59 | 123.87 | |
7 | Nanotoxicology | journal | 2.046 Q1 | 107 | 59 | 190 | 2921 | 1259 | 186 | 6.25 | 49.51 | |
8 | Drug Discovery Today | journal | 2.020 Q1 | 215 | 159 | 449 | 9878 | 3042 | 408 | 6.23 | 62.13 | |
9 | Clinical Pharmacokinetics | journal | 2.140 Q1 | 184 | 78 | 175 | 5515 | 1295 | 165 | 6.14 | 70.71 | |
10 | Pharmacogenomics Journal | journal | 1.503 Q1 | 95 | 75 | 163 | 3320 | 901 | 162 | 5.46 | 44.27 | |
11 | Neuropharmacology | journal | 2.428 Q1 | 191 | 435 | 956 | 31006 | 4802 | 939 | 5.11 | 71.28 | |
12 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.615 Q1 | 99 | 14 | 74 | 2197 | 389 | 68 | 5.04 | 156.93 | |
13 | Journal of Antimicrobial Chemotherapy | journal | 2.479 Q1 | 221 | 505 | 1510 | 13833 | 7718 | 1209 | 5.01 | 27.39 | |
14 | Journal of Nanobiotechnology | journal | 1.154 Q1 | 109 | 51 | 136 | 1693 | 717 | 136 | 4.98 | 33.20 | |
15 | Toxicological Sciences | journal | 1.738 Q1 | 207 | 262 | 846 | 13014 | 4212 | 807 | 4.92 | 49.67 | |
16 | Expert Opinion on Therapeutic Targets | journal | 2.023 Q1 | 106 | 130 | 359 | 11733 | 1726 | 355 | 4.86 | 90.25 | |
17 | Therapeutic Advances in Neurological Disorders | journal | 1.144 Q1 | 68 | 31 | 88 | 2319 | 397 | 86 | 4.82 | 74.81 | |
18 | F1000 Biology Reports | journal | 1.635 Q1 | 32 | 2 | 138 | 163 | 391 | 137 | 4.68 | 81.50 | |
19 | Expert Opinion on Drug Delivery | journal | 1.482 Q1 | 133 | 128 | 326 | 11044 | 1722 | 324 | 4.57 | 86.28 | |
20 | International Journal of Neuropsychopharmacology | journal | 2.121 Q1 | 125 | 202 | 368 | 11376 | 1818 | 354 | 4.52 | 56.32 | |
21 | Environmental Pollution | journal | 1.976 Q1 | 301 | 494 | 1390 | 23832 | 6576 | 1360 | 4.39 | 48.24 | |
22 | Expert Opinion on Investigational Drugs | journal | 1.489 Q1 | 117 | 139 | 452 | 10890 | 1969 | 440 | 4.39 | 78.35 | |
23 | Expert Opinion on Biological Therapy | journal | 1.288 Q1 | 102 | 163 | 471 | 12106 | 1906 | 462 | 3.98 | 74.27 | |
24 | Mutagenesis | journal | 1.195 Q1 | 102 | 84 | 268 | 3765 | 1020 | 259 | 3.79 | 44.82 | |
25 | Journal of Psychopharmacology | journal | 1.592 Q1 | 135 | 129 | 573 | 8018 | 2123 | 541 | 3.71 | 62.16 | |
26 | CNS Neuroscience and Therapeutics | journal | 1.603 Q1 | 91 | 151 | 299 | 5770 | 1229 | 244 | 3.69 | 38.21 | |
27 | Expert Opinion on Drug Discovery | journal | 1.160 Q1 | 84 | 103 | 272 | 10456 | 986 | 272 | 3.68 | 101.51 | |
28 | Toxicology Research | journal | 0.660 Q3 | 47 | 37 | 23 | 1956 | 83 | 22 | 3.61 | 52.86 | |
29 | Expert Review of Vaccines | journal | 1.381 Q1 | 105 | 142 | 459 | 10084 | 1679 | 380 | 3.54 | 71.01 | |
30 | Expert Opinion on Therapeutic Patents | journal | 1.188 Q1 | 88 | 112 | 330 | 9802 | 1165 | 324 | 3.50 | 87.52 | |
31 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.906 Q2 | 100 | 128 | 368 | 11082 | 1279 | 366 | 3.49 | 86.58 | |
32 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 1.299 Q1 | 57 | 68 | 155 | 2448 | 479 | 150 | 3.48 | 36.00 | |
33 | PharmacoEconomics | journal | 1.713 Q1 | 118 | 98 | 282 | 4577 | 995 | 240 | 3.47 | 46.70 | |
34 | Expert Opinion on Emerging Drugs | journal | 0.951 Q2 | 54 | 40 | 136 | 3787 | 434 | 134 | 3.44 | 94.68 | |
35 | Journal of Drug Targeting | journal | 1.020 Q1 | 107 | 96 | 263 | 5108 | 908 | 257 | 3.39 | 53.21 | |
36 | Toxicology in Vitro | journal | 0.933 Q2 | 125 | 279 | 701 | 11248 | 2461 | 695 | 3.39 | 40.32 | |
37 | Antiviral Therapy | journal | 1.554 Q1 | 93 | 135 | 485 | 4647 | 1590 | 466 | 3.22 | 34.42 | |
38 | British Journal of Clinical Pharmacology | journal | 1.272 Q1 | 167 | 276 | 684 | 11724 | 2319 | 534 | 3.22 | 42.48 | |
39 | Journal of Exposure Science and Environmental Epidemiology | journal | 1.282 Q1 | 106 | 87 | 217 | 3380 | 625 | 206 | 3.15 | 38.85 | |
40 | ChemMedChem | journal | 1.147 Q1 | 119 | 238 | 661 | 9017 | 2085 | 638 | 3.14 | 37.89 | |
41 | Journal of Immune Based Therapies and Vaccines | journal | 0.793 Q2 | 21 | 0 | 16 | 0 | 36 | 16 | 3.14 | 0.00 | |
42 | Bioorganic and Medicinal Chemistry | journal | 1.064 Q1 | 187 | 835 | 2421 | 33177 | 8032 | 2412 | 3.12 | 39.73 | |
43 | Chinese Medicine | journal | 0.885 Q2 | 56 | 23 | 112 | 955 | 390 | 105 | 3.11 | 41.52 | |
44 | Journal of Applied Toxicology | journal | 0.812 Q2 | 103 | 168 | 290 | 8182 | 895 | 284 | 3.10 | 48.70 | |
45 | Food and Chemical Toxicology | journal | 1.020 Q2 | 203 | 807 | 1769 | 35395 | 6380 | 1732 | 3.05 | 43.86 | |
46 | Human Genomics | journal | 1.266 Q1 | 68 | 24 | 98 | 1098 | 310 | 88 | 3.05 | 45.75 | |
47 | Tetrahedron | journal | 1.106 Q1 | 236 | 1323 | 3638 | 67114 | 10883 | 3617 | 3.02 | 50.73 | |
48 | Future Medicinal Chemistry | journal | 1.182 Q1 | 90 | 206 | 497 | 11429 | 1484 | 402 | 2.97 | 55.48 | |
49 | Cardiovascular Therapeutics | journal | 1.089 Q1 | 54 | 72 | 190 | 3141 | 609 | 178 | 2.95 | 43.63 | |
50 | Phytochemical Analysis | journal | 0.955 Q2 | 83 | 85 | 248 | 2520 | 798 | 246 | 2.88 | 29.65 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®